AMBEY — Ambey Laboratories Share Price
Last trade - 00:00- IN₹945.48m
- IN₹1.08bn
- IN₹1.05bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4 | ||
| Price to Tang. Book | 4 | ||
| Price to Free Cashflow | 14.89 | ||
| Price to Sales | 0.9 | ||
| EV to EBITDA | 12.75 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.79% | ||
| Return on Equity | 19.33% | ||
| Operating Margin | 5.27% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | 817.39 | 846.01 | 1,048.21 | n/a | n/a | 13.24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -65.42 | +27.99 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ambey Laboratories Limited is an India-based company, which is involved in the business of manufacturing and distribution of agro and home hygiene products. It carries on the activities in the field of manufacturing chemicals, compounds, herbal products, insecticides, pesticides and fungicides. It manufactures and supplies 2,4-D base chemicals. Its Agro-Chemical products include 2,4-D amine salt, 2,4-D acid tech, 2,4-D ethyl ester tech, 2,4-D 2-ethylhexyl ester tech, 2,4-D sodium salt and hexaconazole. Its home hygiene products include black phenyle, white floor cleaner, toilet cleaner, surface & floor cleaner, power cleaner, glass cleaner, moth repellent balls, hand wash, bathroom cleaner and hand sanitizer.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- January 1st, 1970
- Incorporated
- March 20th, 1985
- Public Since
- July 11th, 2024
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 24,946,819
- Address
- B18/9, Dlf Phase -1, Sector 26a, GURGAON, 122002
- Web
- http://www.ambeylab.com/
- Phone
- +91 1244000788
- Auditors
- Kapish Jain & Associates
Similar to AMBEY
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 24:19 UTC, shares in Ambey Laboratories are trading at IN₹37.90. This share price information is delayed by 15 minutes.
Shares in Ambey Laboratories last closed at IN₹37.90 and the price had moved by over the past 365 days. In terms of relative price strength the Ambey Laboratories share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAmbey Laboratories does not currently pay a dividend.
Ambey Laboratories does not currently pay a dividend.
Ambey Laboratories does not currently pay a dividend.
To buy shares in Ambey Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹37.90, shares in Ambey Laboratories had a market capitalisation of IN₹945.48m.
Here are the trading details for Ambey Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: AMBEY
Based on an overall assessment of its quality, value and momentum Ambey Laboratories is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ambey Laboratories. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -35.06%.
As of the last closing price of IN₹37.90, shares in Ambey Laboratories were trading -38.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ambey Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹37.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Ambey Laboratories' directors